martes, 14 de abril de 2026

177Lu-PSMA-617 Delays Disease Progression in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Edited by Vineeta Teotia Medscape UK April 13, 2026

https://www.medscape.com/viewarticle/177lu-psma-617-delays-disease-progression-patients-2026a1000at7

Vaccination Protects Young Men From HPV-Related Cancers Kaitlin Sullivan April 13, 2026

https://www.medscape.com/viewarticle/vaccination-protects-young-men-hpv-related-cancers-2026a1000bgt

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC Edited by Gargi Mukherjee April 14, 2026

https://www.medscape.com/viewarticle/weight-based-and-fixed-dose-pembrolizumab-compared-nsclc-2026a1000bjy

Rituximab Linked to Lower Cancer Risk Than Mycophenolate or Azathioprine in Pemphigus Edited by Gargi Mukherjee April 14, 2026

https://www.medscape.com/viewarticle/rituximab-linked-lower-cancer-risk-than-mycophenolate-or-2026a1000bii

CAR T-Cell Therapy Tied to Better Survival in Relapsed LBCL Edited by Gargi Mukherjee April 14, 2026

https://www.medscape.com/viewarticle/car-t-cell-therapy-tied-better-survival-relapsed-lbcl-2026a1000bka

Scotland Clears New Option for EGFR Lung Cancer Edited by Zeel Mehta Medscape UK April 14, 2026

https://www.medscape.com/viewarticle/scotland-clears-new-option-egfr-lung-cancer-2026a1000bk2

HER2 ADC Shows Promise in Recurrent Endometrial Cancer Megan Brooks April 14, 2026

https://www.medscape.com/viewarticle/her2-adc-shows-promise-recurrent-endometrial-cancer-2026a1000bl0